Parameter | Total n = 637 |
---|---|
Gender | |
male | 79.4% (506/637) |
female | 20.6% (131/637) |
Age at initial diagnosis BCa (mean ± SD; years) | 72.5 ± 11.5 |
T stage BCa at initial diagnosis | |
pTa | 41.8% (266/637) |
pT1 | 30.0% (191/637) |
pT2 | 26.7% (170/637) |
pT3 | 0.3% (2/637) |
pT4 | 0.2% (1/637) |
pTis | 0.5% (3/637) |
PUNLMP | 0.5% (3/637) |
unknown | 0.2% (1/637) |
Concomitant CIS at initial diagnosis | |
yes | 7.5% (48/637) |
no | 92.5% (589/637) |
Grading (WHO 1973) BCa at initial diagnosis | |
G1 | 18.7% (119/637) |
G2 | 44.4% (283/637) |
G3 | 36.6% (233/637) |
unknown | 0.3% (2/637) |
Grading (WHO 2004) BCa at initial diagnosis | |
low-grade | 20.4% (130/637) |
high-grade | 74.9% (477/637) |
unknown | 4.7% (30/637) |
Hydronephrosis | |
no | 86.8% (553/637) |
left | 3.8% (24/637) |
right | 4.6% (29/637) |
bilateral | 4.9% (31/637) |
Urinary drainage of the upper urinary tract | |
no | 80.8% (515/637) |
DJ | 11.6% (74/637) |
percutaneous nephrostomy | 5.7% (36/637) |
percutaneous nephrostomy for anterograde DJ | 1.6% (10/637) |
percutaneous nephrostomy and DJ | 0.3% (2/637) |
Upper urinary tract urothelial carcinoma (UUTUC) | |
no | 95.6% (609/637) |
yes | 4.4% (28/637) |
UUTUC prior to BCa | 39.3% (11/28) |
UUTUC synchronous to BCa | 32.1% (9/28) |
UUTUC metachronous to BCa | 28.6% (8/28) |
Death | |
no | 87.9% (560/637) |
yes | 12.1% (77/637) |